Nitric oxide inhalation in neonates with pulmonary hypertension;Inhalatie van stikstofmonoxide bij pasgeborenen met pulmonale hypertensie

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 3, 1998, Pages 123-127

  De Beaufort, A J ^a,b   Slot, H M J ^a,c   Van Bel, F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ARTERIAL OXYGEN TENSION; ARTICLE; ENDOTHELIUM CELL; EXTRACORPOREAL OXYGENATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG HYPOPLASIA; MECONIUM ASPIRATION; PULMONARY HYPERTENSION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADMINISTRATION, INHALATION; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; INFANT, NEWBORN; LUNG; MECONIUM ASPIRATION SYNDROME; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; PNEUMONIA; PULMONARY CIRCULATION; RESPIRATORY DISTRESS SYNDROME, NEWBORN; VASODILATION;

EID: 0032539416     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kinsella JP, Abman SH. Recent developments in the pathopbysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 1995;126 853-64.
2. Morin 3rd FC, Stenmark KR. Persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 1995;151:2010-32
3. Fineman JR, Soifer SJ, Heymann MA. Regulation of pulmonary vascular tone in the perinatal period. Annu Rev Physiol 1995;57:115-34.
4. UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996;348:75-82
5. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
6. Roberts jr JDJ, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87:447-53.
7. Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995;73:65-8.
8. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:818-9.
9. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
10. Beaufort AJ de, Lopes Cardozo RH, Gesink BJ, Hazekamp M, Bel F van. Inhalatie van stikstof-monoxide (NO) bij pulmonale hypertensie: ervaringen in de neonatologie en thoraxchirurgie. Tijdschr Kindergeneeskd 1995;S1:11(A19)
11. Roberts jr JD, Fineman JR, Morin 3rd FC, Shaul PW, Rimar S Schreiber MD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn The Inhaled Nitric Oxide Study Group. N Engl J Med 1997;336:605-10.
12. The Neonatal Inhaled Nitric Oxide Study Group Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
13. Skimming JW, Bender KA, Hutchison AA, Drummond WH. Nitric oxide inhalation in infants with respiratory distress syndrome J Pediatr 1997;130:225-30
14. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
15. Anggard E. Nitric oxide: mediator, murderer, and medicine Lancet 1994;343:1199-206.
16. Bel EE de. Stikstofoxide: nieuw licht op vele klinische syndiomen. Ned Tijdschr Geneeskd 1994;138:650-6
17. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992;258:1898-902.
18. Lopes Cardozo RH, Beaufort AJ de, Gesink BJ, Moison RM, Bor M van de, Berger HM, et al. Inhalation of nitric oxide: effect on cerebral hemodynamics and activity, and antioxidant status in the newborn lamb. Biol Neonate 1996;69:284-92
19. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Guidelines for the safe administration of inhaled nitric oxide Arch Dis Child Fetal Neonatal Ed 1994;70:F47-9.
20. Hogman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G. Bleeding time prolongation and NO inhalation [letter] Lancet 1993; 341:1664-5.
21. Hoffman GM, Ross GA, Day SE, Rice TB, Neun LD. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 1997;25:352-9
22. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowski A, Ryan CA. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 1994; 124:302-8.
23. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993;123:103-8.
24. Barefield ES, Karle VA, Phillips 3rd JB, Carlo WA. Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996;129:279-86.
25. Peliowski A, Finer NN, Etches PC, Tierney AJ, Ryan CA. Inhaled nitric oxide for premature infants after prolonged rupture of the membranes J Pediatr 1995:26:450-3.
26. Karamanoukian HL, Glick PL, Zayek M, Steinhorn RH, Zwass MS, Fineman JR, et al. Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics 1994;94:715-8.
27. Lönnqvist PA, Jonsson B, Wmberg P, Frostell CG. Inhaled nitric oxide in infants with developing or established chronic lung disease. Acta Paediatr 1995;84:1188-92.
28. Buhrer C, Merker G, Falke K, Versmold H, Obladen M Doseresponse to inhaled nitric oxide in acute hypoxemic respiratory failure of newborn infants: a preliminary report Pediatr Pulmonol 1995;19:291-8.
29. Waffarn F, Turbow R, Yang L, Sills J, Hallman M. Treatment of persistent pulmonary hypertension of the newborn: a randomized trial comparing intermittent mandatory ventilation and high frequency oscillatory ventilation for delivering nitric oxide. Pediatr Res 1995; 37:243(A.1446).